Event Details

Event Details

Event Details

Clinical Trials on Alzheimer's Disease conference (CTAD)

11/09/21 - 11/12/21

Supporting Materials

Agenda 5.1 MB

CTAD 2021 presentation: SEMA4D blocking antibody, pepinemab , is a novel potential treatment for neurodegenerative disease: clinical proof of concept in HD supports clinical development in AD 2.8 MB

Title

Clinical Trials on Alzheimer's Disease conference (CTAD)

Date / Time

11/09/21 - 11/12/21

More Information